James Kuhlen, MD
Allergy & Immunology · Greenville, SCNPI 1356662704
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Pharming Healthcare, Inc. at 31.5% of the total. Reporting peaked in 2021 at $3,828 and has fallen 81.9% since, to $692 in 2025. That places this record below the midpoint for allergy & immunology clinicians in SC, where the typical reported total is $7,297.
Across 188 payments — averaging $40.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$2K
- Biocryst US Sales Co., LLC$1K
- AstraZeneca$1K
- Sanofi$1K
- Novartis$223
- Pfizer$171
- plus $1K from 20 others
Across 1 payment — averaging $31,205 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$31K
What the payments were for
- Consulting fees$1,12515%
- Speaking & faculty fees$2,25030%
- Food & beverage$4,17555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 7 | $2,376 |
| Biocryst US Sales Co., LLC | 5 | $1,230 |
| AstraZeneca | 35 | $1,170 |
| Sanofi | 69 | $1,013 |
| Novartis | 9 | $223 |
| Pfizer | 9 | $171 |
| Genentech USA, Inc. | 7 | $142 |
| GSK | 7 | $140 |
| CSL Behring | 6 | $131 |
| Amgen(2 entities) | 6 | $131 |
| AbbVie | 1 | $119 |
| Grifols USA, LLC | 2 | $98 |
| LEO Pharma Inc. | 4 | $96 |
| Shire North American Group Inc | 3 | $87 |
| Incyte Corporation | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Kaleo, Inc. | 2 | $50 |
| Optinose US, Inc. | 2 | $39 |
| Eyevance Pharmaceuticals LLC | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Merck | 1 | $15 |
| Alk-abello, Inc | 1 | $15 |
| USWM, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,550 in reported general payments places this provider in the 50th percentile of 46 allergy & immunology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 39 | $111,610 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $21,967 |
| Ipratropium Bromide | 71 | $2,322 |
| Amoxicillin | 32 | $336 |
| Montelukast Sodium | 31 | $272 |
| Fluticasone Propionate | 20 | $228 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $201 |
| Mupirocin | 11 | $136 |
| Azithromycin | 18 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $98 | $111,61039 claims |
| GSKTrelegy Ellipta | $140 | $21,96729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 46 allergy & immunology providers in South Carolina.
Other allergy & immunology in Greenville
- Douglas JohnstonGreenville$329K
- Reid JohnstoneGreenville$13K
- Rudolph JohnstoneGreenville$10K
- Charles GreeneGreenville$9K
- Andrea LantzGreenville$9K
- Shiven PatelGreenville$7K
- Dennis PaulkGreenville$5K
- Melissa AndersonGreenville$3K
- John PulciniGreenville$2K
- Erin MullaneyGreenville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.